Advertisement
Singapore markets open in 48 minutes
  • Straits Times Index

    3,330.09
    +11.64 (+0.35%)
     
  • S&P 500

    5,306.04
    +1.32 (+0.02%)
     
  • Dow

    38,852.86
    -216.74 (-0.55%)
     
  • Nasdaq

    17,019.88
    +99.08 (+0.59%)
     
  • Bitcoin USD

    68,239.43
    -1,104.02 (-1.59%)
     
  • CMC Crypto 200

    1,480.80
    -15.66 (-1.05%)
     
  • FTSE 100

    8,254.18
    -63.41 (-0.76%)
     
  • Gold

    2,361.40
    +4.90 (+0.21%)
     
  • Crude Oil

    80.29
    +0.46 (+0.58%)
     
  • 10-Yr Bond

    4.5420
    +0.0750 (+1.68%)
     
  • Nikkei

    38,855.37
    0.00 (0.00%)
     
  • Hang Seng

    18,821.16
    -6.14 (-0.03%)
     
  • FTSE Bursa Malaysia

    1,615.82
    -2.45 (-0.15%)
     
  • Jakarta Composite Index

    7,253.63
    +77.21 (+1.08%)
     
  • PSE Index

    6,501.34
    -70.26 (-1.07%)
     

Assertio Holdings First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Assertio Holdings (NASDAQ:ASRT) First Quarter 2024 Results

Key Financial Results

  • Revenue: US$32.4m (down 24% from 1Q 2023).

  • Net loss: US$4.51m (loss widened by 29% from 1Q 2023).

  • US$0.047 loss per share.

earnings-and-revenue-history
earnings-and-revenue-history

All figures shown in the chart above are for the trailing 12 month (TTM) period

Assertio Holdings Revenues Beat Expectations, EPS Falls Short

Revenue exceeded analyst estimates by 9.9%. Earnings per share (EPS) missed analyst estimates by 67%.

Looking ahead, revenue is expected to decline by 4.5% p.a. on average during the next 2 years, while revenues in the Pharmaceuticals industry in the US are expected to grow by 9.3%.

ADVERTISEMENT

Performance of the American Pharmaceuticals industry.

The company's shares are up 25% from a week ago.

Risk Analysis

Be aware that Assertio Holdings is showing 3 warning signs in our investment analysis and 2 of those can't be ignored...

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.